In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cellegy Pharmaceuticals

Latest From Cellegy Pharmaceuticals

Adamis and La Jolla Pharmaceutical to merge

Adamis Pharmaceuticals has entered a merger agreement to acquire fellow US firm La Jolla Pharmaceutical Company. The deal has been approved by both boards of directors and, subject to closing conditions including shareholder approval, is expected to close in the first quarter of next year.

Companies Deals

Europe's New Spec Pharma Models

Spec pharma has created significant value in the US, but not, so far, in Europe. Still, Europe's spec pharma hopefuls aren't giving up, and they're trying out variations on the theme--some starting with infrastructure, others with products.

Europe North America

Ex-Shire Team Builds New Euro-Specialty Group

Archimedes joins a growing new generation of pan-European specialty pharma, highlighting the need for a single commercial partner across Europe and the increasing alternatives to big and mid-sized pharma.

BioPharmaceutical Strategy

Europe's Flavors of Sustainable BioPharma

Europe's financing environment makes it difficult to build big biotech from scratch. But sustainable biopharma firms are nevertheless emerging--mostly through the transformation of existing pharma assets.

BioPharmaceutical Europe
See All

Company Information

UsernamePublicRestriction

Register